References
- Anon. (2002). NCCLS Performance Standards for Anti-microbial Susceptibility Testing; Twelfth International Supplement. Document M100-S12. Wayne, PA: NCCLS.
- Boyce, T. G., Swerdlow, D. L. & Griffin, P. M. (1995). Escherichia coli 0157 and the hemolytic-uremic syndrome. New England Journal of Medicine, 333, 364–368.
- DeVinney, R., Stein, M., Reinscheid, D., Abe, A., Ruschkowski, S. & Finlay, B. B. (1999). Entero-hemorrhagic Escherichia coli 0157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated. Infection and Immunity, 67, 2389–2398.
- Griffin, P. (1995). Escherichia coli 0157:H7 and other enterohemorrhagic Escherichia coli. In Infections of the Gastrointestinal Tract, eds Blaser, M. J., Smith, P. D., Ravdin, J. I., Greenberg, H. B. & Guerrant, R. L. pp. 739-761. New York: Raven Press.
- Griffin, P. M. & Tauxe, R. V. (1991). The epidemiology of infections caused by Escherichia coli 0157:H7, other enterohemorrhagic E. coli, and the hemolytic uremic syndrome. Epidemiological Reviews, 13, 60–98.
- Hofmann, S. L. (1993). Southwestern Internal Medicine Conference: shiga-like toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura. American Journal of the Medical Sciences, 306, 398–406.
- Jackson, M. P. (1990). Structure-function analyses of shiga toxin and the shiga-like toxins. Microbial Pathogenesis, 8, 235–242.
- Karch, H., Meyer, T., Russman, H. & Heesemann, J. (1992). Frequent loss of shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivafion. Infection and Immunity, 60, 3464–3467.
- Kimmitt, P. T., Harwood, C. R. & Barer, M. R. (2000). Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerging Infectious Diseases, 6, 458–465.
- Kresse, A. U., Schulze, K., Deibel, C., Ebel, F., Rohde, M. Chakraborty, T. & Guzman, C. A.(1998). Pas, a novel protein required for protein secretion and attaching and effacing activities of entero-hemorrhagic Escherichia coli. Journal of Bacteriology, 180, 4370–4379.
- Louie, M., de Azavedo, J., Clarke, R., Borczyk, A., Lior, H., Richter, M. & Brunton, J. (1994). Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiology and Infection, 112, 449–461.
- McLigeyo, S. O. (1999). Haemolytic uraemic syn-drome: a review. East African Medical Journal, 76, 148–153 .
- Mead, P. S. & Griffin, P. M. (1998). Escherichia coli 0157:H7. Lancet, 352, 1207–1212.
- Meyers, K. E. C. & Kaplan, B. S. (2000). Many cell types are shiga toxin targets. Kidney International, 57, 2650–2651.
- Naryshkina, T., Mustaev A., Darst, S. A. & Severinov, K. (2001). The 13' subunit of Escherichia coli RNA polymerase is not required for interaction with initiating nucleotide but is necessary for inter-action with rifampicin. Journal of Biological Chemistry, 276, 13,308-13,313.
- Olsvik, O., Rimstad, E., Homes, E., Strockbine, N., Wasteson, Y., Lund, A. & Wachsmuth, K. (1991). A nested PCR followed by magnetic separation of amplified fragments for detection of Escherichia coli shiga-like toxin genes. Molecular and Cellular Probes, 5, 429–435.
- Qadri, S. M. H. & Kayali, S. (1998). Entero-hemorrhagic Escherichia coli: a dangerous food-borne pathogen. Postgraduate Medicine, 103, 179–187.
- Reese, R. E. & Betts, R. F. (1993). Rifampicin. In Handbook of Antibiotics, eds Reese, R. E. & Betts, R. F. pp. 359-369. Boston, MA: Little, Brown and Company.
- Siegler, R. L. (1995). The hemolytic uremic syndrome. Pediatric Nephrology, 42, 1505–1529.
- Smith, H. R. & Scotland, S. M. (1988). Verocytotoxin-producing strains of Escherichia coli. Journal of Medical Microbiology, 26, 77–85.
- Tesh, V. L. & O'Brien, A. D. (1992). Adherence and colonization of mechanisms of enteropathogenic and enterohemorrhagic Escherichia coli. Microbial Pathogenesis, 12, 245–254.
- Tesh, V. L., Burris, J. A., Owens, J. W., Gordon, V. M., Wadolkowski, E. A., O'Brien, A. D. & Samuel, J. E. (1993). Comparison of the relative toxicities of shiga-like toxins type I and type II for mice. Infection and Immunity, 61, 3392–3402.
- Yao, J. D. C. & Moellering Jr, R. C. (1991). Anti-bacterial agents. In Manual of Clinical Microbiology, eds Balows, A., Hausler Jr, W. J., Herrman, K. L., Isenberg, H. D. & Shadomy, J. pp. 1065-1098. Washington, DC: American Society for Microbiology.